The Exclusive Synthesis & Catalysts business unit focuses on the development of custom-tailored synthesis and catalysts, particularly for the pharmaceuticals field, and markets Evonik's extensive technological expertise in the area of chemistry and catalysis. Through its global network of sites, the business unit offers seamless services ranging from lab-scale synthesis development to commercial-scale production. It is also a leader in catalytic system solutions, supplying a broad portfolio of highly specialized biocatalysts and homogeneous and heterogeneous catalysts as well as complete service for the life science, fine chemicals, industrial chemicals, intermediates and polymer industries. Offering both catalysis and synthesis opens up further synergies for the business unit, leading to efficient problem-solving solutions for its customers. Exclusive Synthesis & Catalysts generated sales of about €335 million in 2005, and operates 18 locations with over 2,300 employees in Europe, the NAFTA region, Asia, and South America.